- Fourth QuarterANDA Litigation Settlements
- Bausch Health Ireland Ltd. v. Padagis Israel Pharms. Ltd.
- Recent Litigation Disputes Involving Generative AI
- 2023 Bulletin - Third QuarterGENERICally Speaking: A Hatch-Waxman Litigation Bulletin 2023 Q3
- Third QuarterANDA Approvals
- Third QuarterANDA Litigation Settlements
- Third QuarterGeneric Launches
- Third QuarterNew ANDA Cases
- October 9, 2023Q&A: The Crossroads Where Generative AI Meets Copyright Law
- Fourth QuarterGeneric Launches
- Fourth QuarterNew ANDA Cases
- Fourth QuarterANDA Approvals
- Novartis Pharms. Corp. v. Alembic Pharms. Ltd.
- CMP Development, LLC v. Amneal Pharms. LLC
- Allergan USA, Inc. v. MSN Labs. Private Ltd.
- Takeda Pharms. U.S.A., Inc. v. Mylan Pharms., Inc.
- September 2023Walking the Razor’s Edge: Client Capacity and the Attorney-Client Relationship
- September 2023Meet Our Keynote Speaker: Journalist and New York Times Contributor Katie Engelhart
- September 2023Evenstad Family Trial Aftermath: Rule 408 May Not Be Used as a Sword and Shield
- September 8, 2023Zogenix, Inc. v. Apotex Inc.
- September 8, 2023Purdue Pharma L.P. v. Accord Healthcare Inc.
- Colorado Expands Antitrust Protection
- July 18, 2023Copyright: Rights Even Heroes Can't Protect
- UCB, Inc. v. Annora Pharma Priv. Ltd.
- Taiho Pharm. Co., Ltd. v. Eugia Pharma Specialties Ltd.
- August 2023Minnesota Passes Survivorship Bill, Expanding Justice for Victims of Medical Malpractice and Wrongful Death
- August 2023Minnesota Bans Non-Competes Formed on or After July 1, 2023
- August 7, 2023Pointers For Tackling Antitrust Class Action Set-Aside Orders
- Second QuarterGenerically Speaking: A Hatch-Waxman Litigation Bulletin
- Mallory Gives Plaintiffs a Better Shot at Justice
- United Therapeutics Corp. v. Liquidia Technologies, Inc.
- Second QuarterANDA Approvals
- Second QuarterANDA Litigation Settlements
- Second QuarterGeneric Launches
- Second QuarterNew ANDA Cases
- Orexo AB v. Sun Pharm. Indus. Ltd.
- July 7, 2023PTAB Overruled: A New Analysis For Real Party In Interest
- July 7, 2023In re Entresto Patent Litigation
- July 6, 2023Artistry No Excuse for Trademark Infringement Where Use is Source Identifying
- July 6, 2023Novartis Pharms. Corp. v. Mylan Pharms. Inc.
- July 2023The Sedona Conference Commentary on the Governance and Management of Trade Secrets
- Sanofi-Aventis U.S. LLC v. Sandoz, Inc.
- June 2023On the Emotional Costs of Litigation
- June 2023Chaos v. Predictability: The Enforceability of Choice of Law Provisions
- June 2023Attorney Spotlight: Partner Christina M. Lincoln
- June 2023I Love Insurance and My Dog: Pet Insurance 101
- June 2023Understanding Fiduciary Duties and Obligations in Investment and Divestment
- June 2023Top Five Writing Tips for Everyday Writing
- June 2023The Blame Game: Can Cyber Crimes Fall Under the War Exclusion?
- June 2023Lessons from the Trial Trenches: How to Avoid Large Adverse Verdicts
